News
Pfizer Pays $11.6 Billion For Migraine Partner Biohaven
Pfizer is putting its substantial gain from COVID-19 drugs to good use by making deals. The company has decided it wants more, six months...
News
Can BHRT – Bioidentical Hormone Therapy in Maryland – Treat Hormonal Imbalance
The human body is a perfect assembly consisting of many parts that work in perfect harmony. Each of them has its own responsibilities and...
Press Releases
ArisGlobal Acquires Boehringer Ingelheim’s Signal Analytics Engine, Bringing Enhanced and Unmatched Pharmacovigilance Capabilities to Life Sciences Industry
ArisGlobal, the global market leader in drug safety solutions worldwide, and Boehringer Ingelheim, a leading research-driven biopharmaceutical company, announced the acquisition of Boehringer Ingelheim’s...
News
Two Years On, Half of COVID-19 Patients Still Symptomatic
As per a new study that may be one of the oldest and largest on record to track people with protracted COVID, the vast...
Press Releases
Berry Global, PYLOTE Introduce Activated Rispharm at Pharmapack 2022 in Paris
Activated Rispharm™, the first-to-market multidose antimicrobial dropper to help prevent eye microbial infections for patients, will be introduced at Pharmapack 2022 (18th & 19th...
Press Releases
Emmes launches Advantage eClinical as a standalone cloud native clinical technology platform
Emmes – a global, full-service Contract Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, announces that it will introduce...
News
Boosters For COVID-19 Might Be Far More Crucial Than Before
The Biden administration estimates that up to 100 million additional individuals could contract COVID-19 in the fall and winter due to diminishing immunity and...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read